Journals / Sağlık Bilimlerinde Değer / 2022 / Cilt: 12 Sayı: 3

Polyphenols in New Treatment Approaches in Age-Related Macular Degeneration

Yaşa Bağlı Makula Dejenerasyonunda Yeni Tedavi Yaklaşımlarında Polifenoller

Pages
573–577
Publication Date
2022-09-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review article, the role of polyphenols in the prevention of retinal diseases such as AMD and effective treatment approaches are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Age-related macular degeneration (AMD) is a retinal disease that affects millions of people world wide.
📊
Key Findings & Data:Although the prevalence of AMD, which is one of the leading causes of irreversible visual impairment in people over 65 years of age, is increasing rapidly, there is no effective treatment for vision loss.
💡
Conclusion & Impact:In this review article, the role of polyphenols in the prevention of retinal diseases such as AMD and effective treatment approaches are discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Antioksidan · nöroprotektif · oksidatif stres

Abstract

Age-related macular degeneration (AMD) is a retinal disease that affects millions of people world wide. It is a multi factorial disease characterized by vision loss as a result of neurogeneration of the retinal pigment epithelium (RPE) and photoreceptors of the eye. Although the prevalence of AMD, which is one of the leading causes of irreversible visual impairment in people over 65 years of age, is increasing rapidly, there is no effective treatment for vision loss. With current studies, although the pharmacotherapy of AMD is still not at the desired level, the course of the disease is slowed down by antioxidant treatments. The fact that polyphenols found in many fruits and vegetables have antioxidant properties as well as anticancer, anti-inflammatory, anti-apoptotic properties has been a hope for the prevention of AMD. Recently, studies have been published indicating a role for polyphenols in the prevention of AMD. Studies showing that polyphenols with strong antioxidant properties have neuroprotective effects on chronic inflammation and apoptotic pathways, in addition to direct ROS scavenging against oxidative damage, also support this view. In this review article, the role of polyphenols in the prevention of retinal diseases such as AMD and effective treatment approaches are discussed.

Özet

Yaşa bağlı makula dejenerasyonu (YBMD), dünya çapında milyonlarca insanı etkileyen bir retina hastalığıdır. Gözün retina pigment epiteli (RPE) ve fotoreseptörlerinin nörodejenererasyonu sonucu görme kaybı ile karakterize multifaktöriyel bir hastalıktır. 65 yaş üstü kişilerde geri dönüşü olmayan görme bozukluğunun önde gelen sebepleri arasında yer alan, YBMD’nin prevalansı hızla artmasına karşın, oluşan görme kaybının etkin bir tedavisi yoktur. Güncel çalışmalar ile, YBMD’nin farmakoterapisi hala istenen düzeyde olmasa da antioksidan tedaviler ile hastalığın seyri yavaşlatılmaktadır. Bir çok meyve ve sebzede bulunan polifenollerin antikanser, anti-inflamatuar, antiapoptotik özelliklerinin yanı sıra antioksidan özelliğe de sahip olması YBMD’nin önlenmesi için bir umut olmuştur. Son zamanlarda, polifenollerin YBMD’nin önlenmesinde rolü olduğuna işaret eden çalışmalar yayınlanmıştır. Güçlü antioksidan özelliğe sahip polifenollerin oksidatif hasara karşı doğrudan reaktif oksijen türlerini (ROS) süpürme dışında, kronik inflamasyon ve apoptotik yolaklar üzerinden nöroprotektif etkisi olduğunu gösteren çalışmalar da bu görüşü desteklemektedir. Bu derleme yazısında polifenollerin YBMD gibi retina hastalıklarının önlenmesinde ki rolü ve etkin tedavi yaklaşımları irdelenmiştir.

🔖

Cite This Article

KURT, A. H., ÖZTABAĞ, C. K., KAYMAZ, A. (2022). Polyphenols in New Treatment Approaches in Age-Related Macular Degeneration. Sağlık Bilimlerinde Değer, Cilt: 12 Sayı: 3, 573–577. https://ajindex.com/articles/904132

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106-16. Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020;117: 513-9.
  2. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997; 104(1): 7-21.
  3. Abdelsalam A, Priore LD, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999; 44 (1): 1-29.
  4. Parmet S, Lynm C, Glass RM. Age-related macular degeneration. JAMA. 2006; 295(20): 2438. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988; 2(5): 552-77.
  5. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102: 1640-2. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004; 122(4): 598-614.
  6. Gordois A, Cutler H, Pezzullo L. An estimation of the worldwide economic and health burden of visual impairment. Global Public Health. 2012; 7(5): 465-81. Calderón-Larrañaga A, Vetrano DL, Welmer AK, Grande G, Fratiglioni L, Dekhtyar S. Psychological correlates of multimorbidity and disability accumulation in older adults. Age and ageing. 2019; 48(6): 789-96.
  7. Al-Zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clinical interventions in aging. 2017; 12: 1313. Brown D, Heier JS, Boyer DS, Freund KB, Kaiser P, Sarraf JEKD. Current best clinical practices-management of neovascular AMD. J VitreoRetinal Dis. 2017; 1(5): 294-7.
  8. Karaçorlu SA, Karaçorlu M. Makula hastalıkları. P: Aydın P, Akova YA. editörler. Temel Göz Hastalıkları: Ankara: Güneş Tıp Kitabevleri; 2010. p. 559-73. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflügers Archiv-European Journal of Physiology. 2010; 459(6): 923-39.
  9. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys. 1990; 280: 1-8. Rana A,Samtiya M,Dhewa T,Mishra V,Aluko RE. Health benefits of polyphenols: A concise review. journal of food biochemistry. 2022; e14264. Kalt W, Hanneken A, Milbury P, Tremblay F. Recent research on polyphenolics in visi